BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16487326)

  • 21. Extensive heterozygosity at four microsatellite loci flanking Plasmodium vivax dihydrofolate reductase gene.
    Alam MT; Agarwal R; Sharma YD
    Mol Biochem Parasitol; 2007 Jun; 153(2):178-85. PubMed ID: 17418906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase.
    Hawkins VN; Suzuki SM; Rungsihirunrat K; Hapuarachchi HC; Maestre A; Na-Bangchang K; Sibley CH
    Am J Trop Med Hyg; 2009 Aug; 81(2):348-55. PubMed ID: 19635897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate Treatment.
    Skacel N; Menon LG; Mishra PJ; Peters R; Banerjee D; Bertino JR; Abali EE
    J Biol Chem; 2005 Jun; 280(24):22721-31. PubMed ID: 15817466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of plasmid R388-encoded type II dihydrofolate reductase as a dominant selective marker in Saccharomyces cerevisiae.
    Miyajima A; Miyajima I; Arai K; Arai N
    Mol Cell Biol; 1984 Mar; 4(3):407-14. PubMed ID: 6325876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar.
    Na BK; Lee HW; Moon SU; In TS; Lin K; Maung M; Chung GT; Lee JK; Kim TS; Kong Y
    Parasitol Res; 2005 Jul; 96(5):321-5. PubMed ID: 15924223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of Plasmodium vivax dihydrofolate reductase determined by homology modeling and molecular dynamics refinement.
    Rastelli G; Pacchioni S; Parenti MD
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3257-60. PubMed ID: 12951104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
    Affleck JG; Al-Batayneh KM; Neumann K; Cole SP; Walker VK
    Eur J Pharmacol; 2006 Jan; 529(1-3):71-8. PubMed ID: 16325803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a yeast protein fragment complementation assay (PCA) system using dihydrofolate reductase (DHFR) with specific additives.
    Shibasaki S; Sakata K; Ishii J; Kondo A; Ueda M
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):735-43. PubMed ID: 18670770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variations of the Plasmodium vivax dihydropteroate synthase gene.
    Menegon M; Majori G; Severini C
    Acta Trop; 2006 May; 98(2):196-9. PubMed ID: 16647679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.
    Nduati E; Hunt S; Kamau EM; Nzila A
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3652-7. PubMed ID: 16127035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel RNA silencing vector to improve antigen expression and stability in Chinese hamster ovary cells.
    Hong WW; Wu SC
    Vaccine; 2007 May; 25(20):4103-11. PubMed ID: 17428585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leucovorin-induced resistance against FDH growth suppressor effects occurs through DHFR up-regulation.
    Oleinik NV; Krupenko NI; Reuland SN; Krupenko SA
    Biochem Pharmacol; 2006 Jul; 72(2):256-66. PubMed ID: 16712799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short hairpin RNA targeted to dihydrofolate reductase enhances the immunoglobulin G expression in gene-amplified stable Chinese hamster ovary cells.
    Wu SC; Hong WW; Liu JH
    Vaccine; 2008 Sep; 26(38):4969-74. PubMed ID: 18602963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
    Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
    J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties.
    Kaiser A; Hammels I; Gottwald A; Nassar M; Zaghloul MS; Motaal BA; Hauber J; Hoerauf A
    Bioorg Med Chem; 2007 Sep; 15(18):6200-7. PubMed ID: 17591443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of malaria in Cameroon. XXII. Geographic mapping and distribution of Plasmodium falciparum dihydrofolate reductase (dhfr) mutant alleles.
    Tahar R; Basco LK
    Am J Trop Med Hyg; 2006 Sep; 75(3):396-401. PubMed ID: 16968912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.